CAS: 485-35-8; (1R,5S)-1,2,3,4,5,6-Hexahydro-8H-1,5-Methanopyrido[1,2-A][1,5]Diazocin-8-One

该化合物是一种植物衍生的藻类,其结构与尼古丁类似,主要来源于青春劳动(Golden Rain acacia) . 它在尼古丁乙酰胆碱受体(nAChRs)中扮演了局部的激动剂,显示出α4β2亚型的高亲近性. 这个药理学剖析使它成为尼古丁毒瘾治疗的候选体,因为它能调节多巴胺释放,减少绞刑和戒烟症状. 临床研究表明,细胞线与其他戒烟疗法相比,可以提供更好的耐性和效率. 它对于氨丙烯乙酰乙胺的选择性可以最大限度地减少目标外效应,从而增强安全性. 该化合物的天然来源和特性机制支持其作为毒瘾药物治疗剂的潜力.

结构式图片

相似化合物

15191-27-2 207390-62-3 20013-22-3

欧盟法规

ECHA物质C&L通报REACH预注册

上下游产品

1,2,3,4,5,6-hexahydro-1,5-methano-pyrido[1,2-a][1,5]diaz°Cin-8-one (6R,7R,9R)-(-)-N-benzyloxycarbonyl-cytisine (3S,5R)-(+)-3-acetoxymethyl-5-formyl-1-piperidine-1-carbvoxylic acid benzyl ester (3S,5R)-3-acetoxymethyl-5-hydroxymethylpiperidine-1-carboxylic acid benzyl esterN-(2-Hydroxyethyl)cytisine (-)-rhombifoline (1R,5S)-3-benzyl-1,2,3,4,5,6-hexahydro-8H-1,5-methanopyrido-[1,2-a][1,5]diaz°Cin-8-one (-)-N-methylcystine

合成工艺路线路线简述

  • 合成目标产物 Cytisine 主要起始原料 1-Piperidinecarboxylic Acid, 3-[(Acetyloxy)Methyl]-5-Formyl-, Phenylmethyl Ester, (3S,5R)-
  • (文献来源)合成步骤主要原料 1-Piperidinecarboxylic Acid, 3-[(Acetyloxy)Methyl]-5-Formyl-, Phenylmethyl Ester, (3S,5R)-

海关参考信息

专利信息


专利号:US-11912647-B2
优先权日:2020-05-22
标 题:Diversity-oriented synthesis of N,N,O-trisubstituted hydroxylamines from alcohols and amines by N—O bond formation
发明人:CRICH DAVID; HETTIKANKANAMALAGE ASIRI; HILL JARVIS
权利人:UNIV GEORGIA
摘要:In one aspect, the disclosure relates to a method for the direct synthesis of complex N,N,O-trisubstituted hydroxylamines by N—O bond formation. In another aspect, the method can successfully be employed using a wide variety of commercially available alcohols and secondary amines and enables the construction of large fragment-based libraries of trisubstituted hydroxylamines for drug discovery purposes. Also disclosed are N,N,O-trisubstituted hydroxylamines having low basicity, high stability at ambient temperatures, and an inherent lack of reactivity towards acetylating and sulfonylating enzymes that confer mutagenicity on less-substituted hydroxylamines.

专利号:US-6362009-B1
优先权日:1997-11-21
标 题 :Solid phase synthesis of heterocycles
发明人:MUNOZ BENITO; CHEN CHIXU
权利人:MERCK & CO INC
摘要:Methods for solid phase and combinatorial synthesis using a resin activation/capture approach are provided. In particular, methods for the production of dihydropyridones, N-acyidihydropyridones, tetrahydropyridones, pyridines, aminopyridines, N-acyltetrahydropyridines and tetrahydropyridines compounds and libraries containing such compounds are provided. Methods for screening the libraries and compounds and pharmaceutical compositions containing compounds prepared by the methods are provided.

专利号:US-9440948-B2
优先权日:2010-09-03
标题:Nicotine compounds and analogs thereof, synthetic methods of making compounds, and methods of use
发明人:KEM WILLIAM READE; SOTI FERENC; ROUCHAUD ANNE; XING HONG; LINDSTROM JON; ANDRUD KRISTIN MARIE
权利人:KEM WILLIAM READE; SOTI FERENC; ROUCHAUD ANNE; XING HONG; LINDSTROM JON; ANDRUD KRISTIN MARIE; UNIV FLORIDA; UNIV PENNSYLVANIA
摘要:Embodiments of the present disclosure provide for compounds such as those shown in FIG. 1.1 (compounds A, B, C, and D), 2′substituted nicotine compounds, azetidine compounds, ether linked nicotine compounds (FIG. 1.2 , compounds E, F, G, and H), methods of synthesis of the compounds, methods of treatment of a condition using compounds A, B, C, D, 2′substituted nicotine compounds, azetidine compounds, or ether linked nicotine compounds, methods of selectively stimulating alpha7 nAChR and/or alpha4beta2 receptors, and the like.

专利号:WO-2023010317-A1
优先权日:2021-08-04
标 题:Method for producing maackiain by means of plant cell fermentation technology
发明人:CAI XIANNENG; Lin Liangli; QIU YUNTING; WU JIAJIA
权利人:HAINAN XINOPEN SOURCE MEDICAL TECH CO LTD
摘要:Disclosed is a method for inducing the production of maackiain by means of a Millettia suspension cell. By means of the method, in a scaled-up culture process of the Millettia suspension cell, by adding two or more of methyl jasmonate, phenylalanine and chitosan glutamate, the shortcomings of existing Millettia suspension culture remaining at a shake flask level, the cell yield being low, and large-scale culture not being able to be carried out are overcome; an optimized culture medium and addition process, both of which are the most optimal for promoting product synthesis, are obtained by means of screening; and the synthesis rate of Millettia maackiain is greatly improved.

专利号:WO-2022213262-A1
优先权日:2021-04-06
标题:Cytisine derivative, and synthesis method therefor, pharmaceutical composition thereof and use thereof
发明人:LIN CHENG-WEN; TSYPYSHEVA INNA; KIU YAN-TUNG; KOVAL'SKAYA ALENA; SAFIULLIN RUSTAM
权利人:LIN CHENG WEN
摘要:The present invention provides a cytisine derivative represented by formula (I), and a synthesis method therefor, a pharmaceutical composition thereof and a use thereof. The cytisine derivative has a structure as shown in formula (I). Symbols in formula (I) are as defined in the description. The cytisine derivative can inhibit the cytopathic effect and infectivity of a dengue virus, and is suitable for use as a drug for preventing and treating the dengue virus.

专利号:US-2005020616-A1
优先权日:2003-07-21
标 题 :Aryl fused azapolycyclic compounds
发明人:COE JOTHAM W; O'DONNELL CHRISTOPHER J
权利人:PFIZER
摘要:This invention is directed to compounds of the formula (I): n n nand their pharmaceutically acceptable salts, wherein R 1 , R 2 , R 3 and Z are as defined herein; intermediates for the synthesis of such compounds, pharmaceutical compositions containing such compounds; and methods of using such compounds in the treatment of neurological and psychological disorders.
常州市宣明医药科技有限公司
⚠️ 未注册 · 未认证企业
⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
数据来源于公开网络搜索,平台未作核实,请自行辨别。
🏢敬请 企业认领
🏬开设公司展台
📢获取免费会员权益
🎖️点亮专属注册企业标签
📇展现公司完整信息 样本查看立即注册认领 →
网址: http://xuanmingchem.com
企业联系电话:0519-85525329👤
📞常州市宣明医药科技有限公司 ⚠️参考联系方式
联系人:刘明;许雯
电话:0519-85525329
手机:15951231113;13646117943
传真:0519-85190960
邮箱:sales@xuanmingchem.com
通信地址: 江苏省常州市新北区汉江路120号
邮编: 213000
🆔 联系时候可告知是从"百琢研"平台获取的信息.
⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

地址:江苏省常州市新北区汉江路120号
⚠️ 未注册 · 未认证企业
注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
陕西帕尼尔生物科技有限公司
⚠️ 未注册 · 未认证企业
⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
数据来源于公开网络搜索,平台未作核实,请自行辨别。
🏢敬请 企业认领
🏬开设公司展台
📢获取免费会员权益
🎖️点亮专属注册企业标签
📇展现公司完整信息 样本查看立即注册认领 →
网址: http://www.pioneerbiotech.com
企业联系电话:029-84385017-8001👤
📞陕西帕尼尔生物科技有限公司 ⚠️参考联系方式
联系人:高经理;肖经理
电话:029-84385017-8001
手机:高经理13259417953
传真:QQ:1477918929
邮箱:sales5@pioneebiotech.com
通信地址: 陕西省西安市未央区凤城十路保利中达广场
邮编: 710000
🆔 联系时候可告知是从"百琢研"平台获取的信息.
⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

地址:陕西省西安市未央区凤城十路保利中达广场
⚠️ 未注册 · 未认证企业
注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
第 1 / 1 页
现货

供应商参考报价(招募中)

品牌试剂参考报价(招募中)

📌 第三方产品分析报告

✅ COA系统入驻 | 共享模式

主要参考文献


1: Walker N, Howe C, Glover M, McRobbie H, Barnes J, Nosa V, Parag V, Bassett B, Bullen C. Cytisine versus nicotine for smoking cessation. N Engl J Med. 2014 Dec 18;371(25):2353-62. doi: 10.1056/NEJMoa1407764. doi: 10.1016/j.neuropharm.2015.03.019. Epub 2015 Mar 31. doi: 10.1002/dta.1707. Epub 2014 Sep 17. doi: 10.1038/npp.2013.216. Epub 2013 Aug 21.
5: Leaviss J, Sullivan W, Ren S, Everson-Hock E, Stevenson M, Stevens JW, Strong M, Cantrell A. What is the clinical effectiveness and cost-effectiveness of cytisine compared with varenicline for smoking cessation? A systematic review and economic evaluation. Health Technol Assess. 2014 May;18(33):1-120. doi: 10.3310/hta18330. Review.
6: Vakhitova YV, Farafontova EI, Zainullina LF, Vakhitov VA, Tsypysheva IP, Yunusov MS. [Search of (-)-Cytisine Derivatives as Potential Inhibitors of NF-κB and STAT1]. Bioorg Khim. 2015 May-Jun;41(3):336-45. Russian. doi: 10.1016/j.jmgm.2015.11.003. Epub 2015 Nov 12. doi: 10.1136/thoraxjnl-2012-203035. Epub 2013 Feb 12. Review. doi: 10.1056/NEJMc1500342. doi: 10.1016/j.pbb.2013.07.012. Epub 2013 Jul 20.

合成参考文献


参考文献:10.1177/1087057116635503
摘要:Voter AF, Manthei KA, Keck JL. A High-Throughput Screening Strategy to Identify Protein-Protein Interaction Inhibitors That Block the Fanconi Anemia DNA Repair Pathway. J Biomol Screen. 2016 Jul;21(6):626–33.
📝 需求与反馈
尽可能描述清楚需求与问题信息
×

通知